OBJECTIVE: The scavenger receptors SR-A and CD36 have been implicated in macrophage foam cell formation during atherogenesis and in the regulation of inflammatory signaling pathways, including those leading to lesional macrophage apoptosis and plaque necrosis. To test the impact of deleting these receptors, we generated Apoe(-/-) mice lacking both SR-A and CD36 and fed them a Western diet for 12 weeks. METHODS AND RESULTS: We analyzed atheroma in mice, assessing lesion size, foam cell formation, inflammatory gene expression, apoptosis, and necrotic core formation. Aortic root atherosclerosis in Apoe(-/-)Cd36(-/-)Msr1(-/-) mice, as assessed by morphometry, electron microscopy, and immunohistochemistry, showed no decrease in lesion area or in vivo foam cell formation when compared to Apoe(-/-) mice. However, Apoe(-/-)Cd36(-/-)Msr1(-/-) lesions showed reduced expression of inflammatory genes and morphological analysis revealed a approximately 30% decrease in macrophage apoptosis and a striking approximately 50% decrease in plaque necrosis in aortic root lesions of these mice. CONCLUSIONS: Although targeted deletion of SR-A and CD36 does not abrogate macrophage foam cell formation or substantially reduce atherosclerotic lesion area in Apoe(-/-) mice, loss of these pathways does reduce progression to more advanced necrotic lesions. These data suggest that targeted inhibition of these pathways in vivo may reduce lesional inflammation and promote plaque stability.
OBJECTIVE: The scavenger receptors SR-A and CD36 have been implicated in macrophage foam cell formation during atherogenesis and in the regulation of inflammatory signaling pathways, including those leading to lesional macrophage apoptosis and plaque necrosis. To test the impact of deleting these receptors, we generated Apoe(-/-) mice lacking both SR-A and CD36 and fed them a Western diet for 12 weeks. METHODS AND RESULTS: We analyzed atheroma in mice, assessing lesion size, foam cell formation, inflammatory gene expression, apoptosis, and necrotic core formation. Aortic root atherosclerosis in Apoe(-/-)Cd36(-/-)Msr1(-/-) mice, as assessed by morphometry, electron microscopy, and immunohistochemistry, showed no decrease in lesion area or in vivo foam cell formation when compared to Apoe(-/-) mice. However, Apoe(-/-)Cd36(-/-)Msr1(-/-) lesions showed reduced expression of inflammatory genes and morphological analysis revealed a approximately 30% decrease in macrophage apoptosis and a striking approximately 50% decrease in plaque necrosis in aortic root lesions of these mice. CONCLUSIONS: Although targeted deletion of SR-A and CD36 does not abrogate macrophage foam cell formation or substantially reduce atherosclerotic lesion area in Apoe(-/-) mice, loss of these pathways does reduce progression to more advanced necrotic lesions. These data suggest that targeted inhibition of these pathways in vivo may reduce lesional inflammation and promote plaque stability.
Authors: Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman Journal: J Biol Chem Date: 2002-10-09 Impact factor: 5.157
Authors: Kathryn J Moore; Joseph El Khoury; Lea A Medeiros; Kinya Terada; Changiz Geula; Andrew D Luster; Mason W Freeman Journal: J Biol Chem Date: 2002-09-17 Impact factor: 5.157
Authors: M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein Journal: J Clin Invest Date: 2000-04 Impact factor: 14.808
Authors: Vidya V Kunjathoor; Diane S Chiu; Kevin D O'Brien; Renée C LeBoeuf Journal: Arterioscler Thromb Vasc Biol Date: 2002-03-01 Impact factor: 8.311
Authors: V R Babaev; L A Gleaves; K J Carter; H Suzuki; T Kodama; S Fazio; M F Linton Journal: Arterioscler Thromb Vasc Biol Date: 2000-12 Impact factor: 8.311
Authors: Sai Kuchibhotla; Difernando Vanegas; David J Kennedy; Ella Guy; George Nimako; Richard E Morton; Maria Febbraio Journal: Cardiovasc Res Date: 2007-12-07 Impact factor: 10.787
Authors: Bo Feng; Dajun Zhang; George Kuriakose; Cecillia M Devlin; Mark Kockx; Ira Tabas Journal: Proc Natl Acad Sci U S A Date: 2003-08-15 Impact factor: 11.205
Authors: Harry Björkbacka; Vidya V Kunjathoor; Kathryn J Moore; Stephanie Koehn; Christine M Ordija; Melinda A Lee; Terry Means; Kristen Halmen; Andrew D Luster; Douglas T Golenbock; Mason W Freeman Journal: Nat Med Date: 2004-03-14 Impact factor: 53.440
Authors: Tae Whan Kim; Maria Febbraio; Peggy Robinet; Brandon Dugar; Diane Greene; Anna Cerny; Eicke Latz; Raymond Gilmour; Kirk Staschke; Guy Chisolm; Paul L Fox; Paul E DiCorleto; Jonathan D Smith; Xiaoxia Li Journal: J Immunol Date: 2011-01-28 Impact factor: 5.422
Authors: Daniel R Anderson; Michael J Duryee; Rajeev K Anchan; Robert P Garvin; Michael D Johnston; Thomas R Porter; Geoffrey M Thiele; Lynell W Klassen Journal: J Biol Chem Date: 2010-10-21 Impact factor: 5.157